> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Guide on Atopic Dermatitis Pediatric Studies
- URL: https://www.fdaweb.com/guide-on-atopic-dermatitis-pediatric-studies-2/
- Published: 2018-10-03T12:00:00.000Z
- Updated: 2026-09-15T00:35:34.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5142509

*Federal Register* notice: FDA has made available a guidance entitled “Atopic Dermatitis: Timing of Pediatric Studies During Development of Systemic Drugs.” The document addresses how early in drug development applicants should incorporate pediatric patients when (XXX SUBSTITUTE XXX)developing systemic drugs for atopic dermatitis (AD). To view the notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2018-10-03/pdf/2018-21519.pdf?ref=fdaweb.com).